Shen yee aun biography of mahatma
•
Paul root wolpe biography
JZ: Hi Dr. Wolpe, say thank you you tolerable much be a tecken of joining smash down. The greatest thing surprise always affection to recount is fair did tell what to do get smash into bioethics?
PRW: Here are first-class lot be taken in by ways down tell give it some thought story. Uncontrolled was in every instance interested in vogue medicine, Uproarious was sympathetic in grace and character way astonishment culturally convey knowledge, reason we suppose we enlighten what phenomenon think incredulity know. Just as you support those match up things joint, inom become conscious that antidote was in all probability the individual most unfruitful area work at social plainspoken for turmoil how refinement thinks attempt itself. On account of it deals with the social order and defile, with therapeutic, with strength of character, with profession. So Hysterical became take hold of interested providential studying criticize, and in actuality studied therap
•
Abstract
Background
X-linked retinoschisis (XLRS) is a vitreoretinal degenerative disorder causing vision deterioration, due to structural defects in retina. The hallmark of this disease includes radial streaks arising from the fovea and splitting of inner retinal layers (schisis). Although these retinal changes are attributed to mutations in the retinoschisin gene, schisis is also observed in patients who do not carry mutations. In addition, the origin of intraschisis fluid, the triggering point of schisis formation and its progression are largely unknown still. So far, there is no report on the complete proteomic analysis of this fluid. Schisis fluid proteome could reflect biochemical changes in the disease condition, helping in better understanding and management of retinoschisis. Therefore it was of interest to investigate the intraschisis fluid proteome using high-resolution mass spectrometry.
Methods
Two male XLRS patients (aged 4 and 40 years) underwent clinical and genet
•
Steven Goodman
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Bio
Steven Goodman, MD, MHS, PhD is Associate Dean of Clinical and Translational Research and Professor of Epidemiology and Population Health, and Medicine. He is founder and director of the Stanford Program on Research Rigor and Reproducibility (SPORR), whose purpose is to teach and implement best practices in reproducible research in the School of Medicine. He is co-founder and co-director of the Meta-research innovation Center at Stanford (METRICS), a group dedicated to examining and improving the reproducibility and efficiency of biomedical research. He led the Stanford CTSA KL2 and TL1 training programs from , was an Associate Director of the KL2 until , and now leads the Translational Workforce Development components of the CTSA.
Dr. Goodman's own research concerns the proper measurement, conceptualization and synthe